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An otherwise healthy female baby who had received early postnatal antibiotic 
prophylaxis because of maternal vaginal group B streptococcal (GBS) colonization 
died of late-onset GBS meningitis. GBS was isolated from blood and cerebrospinal 
fluid. Genotyping using pulsed-field gel electrophoresis confirmed that the GBS isolates 
from the patient were identical to those from her mother’s vagina. Susceptibility 
tests demonstrated no antibiotic resistance. This report provides additional micro-
biologic evidence indicating that early postnatal antibiotic prophylaxis is not effec-
tive in preventing late-onset GBS infections in neonates born to mothers with GBS 
colonization.
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1.  Introduction
Group B streptococcus (GBS) is one of the patho-
gens most commonly responsible for severe bacterial 
infections in neonates.1 Maternal GBS colonization 
in the vagina, which is detected in 10−30% of preg-
nant women, is a major risk factor for neonatal GBS 
sepsis.1−3 Studies comparing the incidences of neo-
natal GBS infections before and after the implemen-
tation of maternal GBS screening and intrapartum 
antibiotic prophylaxis showed that intrapartum an-
tibiotic prophylaxis could reduce the incidence of 
early-onset GBS infection by 70%, from 1.7 cases per 
1000 live births in 1993 to 0.5 cases per 1000 live 
births in 1999.4 However, current prediction and 
prophylaxis of late-onset GBS infection remain unsat-
isfactory. A 9-year period review5 in the United States 
from 1996 to 2004 showed that the incidence of 
late-onset GBS infection remained unchanged at 
0.35 (0.29−0.39) cases per 1000 live births.
Here, we report a case of fatal GBS meningitis 
in a neonate born to a mother with vaginal GBS col-
onization. Direct microbiologic evidence indicated 
that early postnatal antibiotic prophylaxis is not a 
reliable means of blocking mother-to-child trans-
mission of GBS and subsequent development of 
late-onset GBS infections.
2.  Case Report
A female baby was born to a gravida 1, para 1 
mother at 38 weeks of gestation. Maternal vaginal 
GBS colonization was identified during antepartum 
screening at a gestational age of 36 weeks. She re-
ceived one dose of cefazolin (2 g) during labor, and 
the baby was delivered 2 hours later. The Apgar 
scores were 9 at 1 minute and 9 at 5 minutes. Blood 
culture taken immediately after birth was negative. 
The baby received a prophylactic 3-day course of 
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intravenous ampicillin (100 mg/kg/day) and was 
discharged in a stable condition.
The baby remained well and was fed with a mix-
ture of breast milk and infant formula after discharge. 
The mother did not develop mastitis. How ever, the 
infant developed a fever of 39ºC and decreased ac-
tivity at 28 days, and was readmitted the same day. 
A complete blood count revealed leukopenia with 
a white cell count of 2.370 × 109/L and an elevated 
C-reactive protein level of 190 μmol/L (2.0 mg/dL). 
Cerebrospinal fluid (CSF) examination showed hypo-
glycorrhachia with a glucose level lower than 1 mg/
dL (0.056 mmol/L), a blood sugar level of 70 mg/dL 
(3.89 mmol/L), a white cell count of 258 × 11/9/μL 
(L:N = 19:239), and an elevated protein level of 
273.6 mg/dL. Gram staining revealed Gram-positive 
diplococci, and the rapid latex agglutination test was 
positive for GBS. Intravenous ampicillin (300 mg/
kg/day) and Claforan (200 mg/kg/day) were adminis-
tered immediately for GBS meningitis. GBS isolates 
from blood and CSF were susceptible to ampicillin or 
penicillin (minimum inhibitory concentration for pen-
icillin < 0.0325 mg/L). Penicillin G (450,000 units/kg/
day) was initiated on the seventh hospital day, for 
21 days. Antibiotics were then changed to benzathine 
penicillin, at a dose of 50,000 units/kg three times 
per week on the 29th hospital day. Repeated CSF ex-
amination on the ninth hospital day showed a white 
cell count of 34 × 11/9/μL, a protein level of 373.4 mg/
dL, and a glucose level of 50 mg/dL (2.78 mmol/L).
During hospitalization, the infant developed sei-
zures, hypotension, cerebral edema, dilated ventri-
cles, and hypothalamic dysfunction. Brain magnetic 
resonance imaging, performed on the 33rd day, re-
vealed extensive brain damage and atrophy. Despite 
aggressive therapy and supportive measures for 31 
days, the infant died at the age of 59 days.
Genotyping of GBS isolates was performed using 
pulsed-field gel electrophoresis after digestion with 
the SmaI restriction enzyme.6 The results showed 
identical patterns for the GBS isolates cultured from 
the blood and spinal fluid of the baby and the vagi-
nal swab collected from her mother at the same 
time (Figure 1).
3.  Discussion
GBS is the most common pathogen responsible for 
perinatal bacterial infections, contributing to 36% 
of early-onset neonatal sepsis in Taiwan.7 Prenatal 
GBS screening is currently not mandatory in Taiwan. 
However, if prenatal GBS cultures show positive 
results, then the mother receives intrapartum an-
tibiotic prophylaxis, as recommended.1,4
Late-onset GBS infections in neonates who have 
received perinatal antibiotic prophylaxis are not 
uncommon. For example, Glasgow et al8 reported 
that four (57.1%) of the seven cases with late-onset 
GBS infection had received intrapartum antibiotic 
prophylaxis. Similarly, Lin et al3 reported that 52 
(42.6%) of the 122 patients with late-onset GBS in-
fections had received early postnatal antibiotic 
prophylaxis. However, molecular studies demon-
strating the origin of the GBS are lacking. The cur-
rent case provides evidence that early postnatal 
antibiotic prophylaxis is not adequate for blocking 
GBS transmission from mothers to their babies.
The pathogenesis of late-onset GBS sepsis remains 
elusive. Some authorities believe that late-onset 
GBS sepsis reflects delayed infection after early col-
onization. The observations of Moylett et al9 that 
twin babies with recurrent GBS infections support 
the idea that persistent mucosal colonization with 
the original GBS strain, rather than new acquisi-
tion, is responsible for late-onset or recurrent GBS 
infections. In addition to maternal vertical trans-
mission, GBS can also be acquired from various 
other sources, including the environment and from 
caregivers other than the mother. Breast milk is also 
a possible source of late-onset GBS infection.10
In the current case, the mother was a known GBS 
carrier, and the GBS genotype isolated from the 
baby was the same as that of the maternal vaginal 
colonization. Two possible origins of the GBS infec-
tion therefore exist. First, the baby may have ac-
quired GBS from her mother during delivery; 
ampicillin prophylaxis could have failed to eradi-
cate the GBS, which replicated and caused the dis-
ease after a few weeks of asymptomatic carriage. 
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Figure 1 Bacterial DNA samples from patient’s blood (1) 
and cerebrospinal fluid (2), maternal vaginal swab (3), 
and two controls from independent patients (4 and 5) 
were digested with SmaI and subjected to pulsed-field 
gel electrophoresis. The results showed that strains 1−3 
were identical.
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It is also possible, however, that ampicillin prophy-
laxis did eradicate the GBS in the baby, who subse-
quently reacquired the infection during breast 
feeding and care by her GBS-carrying mother.
In conclusion, although maternal GBS screening 
and prophylactic antibiotics are effective for pre-
venting early-onset GBS infection, they are not ad-
equate for preventing late-onset GBS infections. 
Caution should be taken, as antibiotic usage does 
not necessarily eradicate GBS colonization. Reports 
have revealed that throat and rectal swab cultures 
still grew GBS, even after complete treatment of 
infection episodes.9,11 Perinatal antibiotic prophy-
laxis could lead to a false sense of security, and thus 
delay the diagnosis of late-onset GBS diseases. A 
higher index of suspicion and close observation are 
mandatory for the detection of late-onset GBS in-
fections, even in infants born to mothers with GBS 
colonization, and who have received early postna-
tal antibiotic prophylaxis.
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